RecruitingNot ApplicableNCT06560294

Glue Embolization vs Conservative Treatment for Pelvic Congestion Syndrome

Glue Embolization Versus Conservative Treatment for Pelvic Congestion Syndrome: A Randomized Trial


Sponsor

Tanta University

Enrollment

40 participants

Start Date

Aug 17, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The aim of this study is to compare glue embolization and conservative treatment for pelvic congestion syndrome regarding safety and efficacy.


Eligibility

Sex: FEMALEMin Age: 30 YearsMax Age: 50 Years

Inclusion Criteria2

  • Women aged from 30 to 50 years.
  • Complaining from pelvic congestion syndrome.

Exclusion Criteria6

  • Pregnant women at any gestational age, women who gave birth less than 12 months ago, and breastfeeding mothers.
  • Patients who are treated with opiates to reduce pelvic pain in the period before the study.
  • Patient with history of contrast allergy
  • Patient with renal impairment
  • Patient has alternative gynecological cause of chronic pelvic pain as pelvic inflammatory disease (PID), endometriosis, fibroid, adenomyosis, ovarian cyst
  • Patient underwent any previous intervention for pelvic congestion syndrome as laparoscopy or surgery.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGMicronized purified flavonoid fraction (Daflon ®)

Patients will receive micronized purified flavonoid fraction (Daflon ®), 500 mg twice/daily for 3 months.

OTHERGlue embolization

Patients will receive transcatheter glue embolization.


Locations(1)

Tanta University

Tanta, ElGharbia, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06560294


Related Trials